中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

19 records (took 0.026 seconds)

    Patient directed therapy control
    1.
    发明授权
    Patient directed therapy control 有权

    公开(公告)号：US10258798B2

    公开(公告)日：2019-04-16

    申请号：US15012646

    申请日：2016-02-01

    Applicant: Medtronic, Inc.

    Inventor： Eric J. Panken ,  Timothy J. Denison ,  Gregory F. Molnar

    IPC: A61N1/36 ,  A61B5/00 ,  A61M5/142 ,  A61M5/172 ,  A61N1/372 ,  G06F3/01 ,  A61B5/048

    Abstract: A patient controls the delivery of therapy through volitional inputs that are detected by a biosignal within the brain. The volitional patient input may be directed towards performing a specific physical or mental activity, such as moving a muscle or performing a mathematical calculation. In one embodiment, a biosignal detection module monitors an electroencephalogram (EEG) signal from within the brain of the patient and determines whether the EEG signal includes the biosignal. In one embodiment, the biosignal detection module analyzes one or more frequency components of the EEG signal. In this manner, the patient may adjust therapy delivery by providing a volitional input that is detected by brain signals, wherein the volitional input may not require the interaction with another device, thereby eliminating the need for an external programmer to adjust therapy delivery. Example therapies include electrical stimulation, drug delivery, and delivery of sensory cues.

    Collecting gait information for evaluation and control of therapy
    2.
    发明授权
    Collecting gait information for evaluation and control of therapy 有权

    公开(公告)号：US10251595B2

    公开(公告)日：2019-04-09

    申请号：US15439152

    申请日：2017-02-22

    Applicant: Medtronic, Inc.

    Inventor： Kenneth T. Heruth ,  Keith A. Miesel ,  Gregory F. Molnar

    IPC: A61N1/37 ,  A61B5/00 ,  A61B5/0488 ,  A61B5/103 ,  A61N1/36 ,  A61B5/03 ,  A61B5/11 ,  A61M5/172 ,  G06F19/00

    Abstract: A medical device delivers a therapy to a patient. The medical device or another device may periodically determine an activity level or gait parameter of the patient, and associate each determined level or parameter with a current therapy parameter set. A value of at least one activity metric is determined for each of a plurality of therapy parameter sets based on the activity levels or parameters associated with that therapy parameter set. Whether the patient is currently experiencing or anticipated to experience gait freeze caused by their neurological disorder, such as Parkinson's disease, may also be determined. Gait freeze events may be associated with current therapy parameters and used to determine activity metric values. In some examples, the activity metric associated with certain therapy parameters may be presented to a user.

    INCONTINENCE THERAPY
    3.
    发明申请
    INCONTINENCE THERAPY 有权
    不良治疗

    公开(公告)号：US20160367803A1

    公开(公告)日：2016-12-22

    申请号：US15256369

    申请日：2016-09-02

    Applicant: Medtronic, Inc.

    Inventor： Xuan K. Wei ,  Eric H. Bonde ,  Keith A. Miesel ,  Mark S. Lent ,  Gregory F. Molnar

    IPC: A61N1/36 ,  A61N1/372 ,  A61N1/05

    CPC classification number: A61N1/36007 ,  A61N1/0514 ,  A61N1/0551 ,  A61N1/36128 ,  A61N1/36135 ,  A61N1/37235 ,  A61N1/37252

    Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.

    Abstract translation: 用于管理尿失禁或大便失禁的技术包括递送第一类型的治疗以产生第一生理反应，并且在检测到触发事件时，递送第二类型的治疗以产生第二生理反应。 第一种类型的治疗可以基本上定期地递送，而第二种类型的治疗根据需要被递送以提供额外的治疗效果。 用于激活第二类治疗的递送的触发事件可以包括来自传感器的输入，其指示膀胱状况，患者活动水平或患者姿势或患者输入。 在一些例子中，治疗是刺激疗法。

    INCONTINENCE THERAPY
    7.
    发明申请
    INCONTINENCE THERAPY 审中-公开

    公开(公告)号：US20160030741A1

    公开(公告)日：2016-02-04

    申请号：US14880066

    申请日：2015-10-09

    Applicant: Medtronic, Inc.

    Inventor： Xuan K. Wei ,  Eric H. Bonde ,  Keith A. Miesel ,  Mark S. Lent ,  Gregory F. Molnar

    IPC: A61N1/36 ,  A61N1/05

    CPC classification number: A61N1/36007 ,  A61N1/0514 ,  A61N1/0551 ,  A61N1/36128 ,  A61N1/36135 ,  A61N1/37235 ,  A61N1/37252

    Abstract: Techniques for managing urinary or fecal incontinence include delivering a first type of therapy to generate a first physiological response and, upon detecting a trigger event, delivering a second type of therapy to generate a second physiological response. The first type of therapy can be delivered on a substantially regular basis, while the second type of therapy is delivered as needed to provide an additional boost of therapy. The trigger event for activating the delivery of the second type of therapy may include input from a sensor that indicates a bladder condition, patient activity level or patient posture, or patient input. In some examples, the therapy is stimulation therapy.

Patent Agency Ranking